Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Melanoma 9Lung Neoplasms 5Colorectal Neoplasms 5Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Colonic Neoplasms 3Thyroid Neoplasms 1Thyroid Diseases 1Spinocerebellar Degenerations 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Non-small Cell Carcinoma 1Neurofibromatosis 1 1Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia 1Hereditary Sensory and Autonomic Neuropathies 1Glioma 1Gastrointestinal Stromal Tumors 1Fallopian Tube Neoplasms 1Disease Progression 1Central Nervous System Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Brain Neoplasms 1Brain Diseases 1Blast Crisis 1

Interventions

binimetinib 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Advanced and Selected Solid Tumors × binimetinib × Clear all
NCT01449058 2017-10-02

A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors

Array BioPharma

Phase 1 Completed
139 enrolled
Other solid neoplasm

Advanced and Selected Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡